Biovie Inc share price logo

Biovie Inc Share Price

NASDAQ: BIVIW

$0.25

-0.07

(-21.41%)

as on

Biovie Inc Stock Performance

as on March 25, 2026 at 4:54 am IST

  • $0.25
    $0.25

  • 52 Week's Low

    52 Week's High

    $0.20
    $0.52
    downward going graph

    20.00%

    Downside

    108.00%

    Upside

    downward going graph

Biovie Inc share price movements today

Previous Close
$0.32
Open
$0.25
Volume
696.0
Day's Low - High
$0.25 - $0.25
52 Week Low - High
$0.20 - $0.52

Biovie Inc Historical Returns

1 Month Return
+ 37.93 %
3 Month Return
-0.31 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Biovie Inc Stock Fundamentals & Key Indicators

Check Biovie Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-80.74%

Biovie Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biovie Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Biovie Inc image
Biovie Inc
NA$-NANA0.00%
Insmed Incorporated image
Insmed Incorporated
BUY$31.0B317.7%-16.34-210.54%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B126.75%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.49%29.6832.94%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B58.91%17.6731.41%

Biovie Inc Stock’s Investor Sentiment and Interest

Search interest for Biovie Inc Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Biovie Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
Operating Income
-7
-4
-4
-7
-2
-3
-5
-6
EBITDA
-
-
-
-
-
-
-
-
Interest Expense
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
Income Before Tax
-8
-4
-4
-7
-2
-3
-5
-6
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
-8
-4
-4
-7
-2
-3
-5
-6
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Biovie Inc Annual Profit & Loss

All numbers in Millions USD

Jun 2021
Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Income
-7
-27
-45
-32
-18
EBITDA
-
-
-
-
-
Interest Expense
0
2
4
2
0
Depreciation
0
0
0
0
0
Income Before Tax
-130
-26
-50
-32
-17
Income Tax Expense
-
-
-
-
-
Net Income
-130
-26
-50
-32
-17
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Biovie Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-8
-4
-4
-7
-2
-3
-5
-6
Operating Cash Flow
-5
-4
-3
-8
-1
-5
-3
-4
Investing Cash Flow
-
-
-
-
-
-
-
-
Financing Cash Flow
15
-2
0
12
-
-
10
-
Change in Cash
10
-6
-3
4
-1
-5
7
-4

Biovie Inc Annual Cash Flow

All numbers in Millions USD

Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-26
-50
-33
-17
Operating Cash Flow
-18
-40
-27
-19
Investing Cash Flow
-
-
-
-
Financing Cash Flow
33
55
17
12
Change in Cash
14
0
4
-6

Insights on Biovie Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, BIVIW stock has moved down by -16.7%

About Biovie Inc

BioVie Inc. is a clinical stage biotechnology company engaged in the discovery, development and commercialization of therapies targeting life-threatening complications of liver cirrhosis. The Company's initial disease target is ascites a condition impacting people globally. BioVie is based out of the United States.
OrganisationBiovie Inc
Headquarters680 W. Nye Lane, Carson City, NV, United States, 89703
CEOMr. Cuong Viet Do M.B.A.
E-voting on sharesClick here to vote

Key Management of Biovie Inc

Name

Title

Dr. Christopher L. Reading Ph.D.

Senior Vice President of Alzheimer's Disease Program

Mr. David Morse

Senior VP & Chief Regulatory Officer

Mr. Cuong Viet Do M.B.A.

President, CEO & Director

Dr. Joseph M. Palumbo M.D.

Executive VP of R&D and Chief Medical Officer

Mr. Clarence N. Ahlem

Senior Vice President of Operations

Dr. Penelope Markham Ph.D.

Senior Vice President of Liver Disease Program

Ms. Denise Smith

Senior Vice President of Manufacturing & Development

FAQs

What is Biovie Inc share price today?

Biovie Inc share price today is $0.25 as on at the close of the market. Biovie Inc share today touched a day high of $0.25 and a low of $0.25.

What is the 52 week high and 52 week low for Biovie Inc share?

Biovie Inc share touched a 52 week high of $0.52 on and a 52 week low of $0.2 on . Biovie Inc stock price today i.e. is closed at $0.25,which is 51.92% down from its 52 week high and 25.00% up from its 52 week low.

How to invest in Biovie Inc Stock (BIVIW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biovie Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biovie Inc Shares that will get you 6.0000 shares as per Biovie Inc share price of $0.25 per share as on March 24, 2026 at 11:24 pm IST.

What is the minimum amount required to buy Biovie Inc Stock (BIVIW) from India?

Indian investors can start investing in Biovie Inc (BIVIW) shares with as little as ₹93.734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Biovie Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Biovie Inc share’s latest price of $0.25 as on March 24, 2026 at 11:24 pm IST, you will get 40.0000 shares of Biovie Inc. Learn more about fractional shares .